Danaher (DHR) Cash from Financing Activities (2009 - 2026)
Danaher (DHR) posted Cash from Financing Activities of $7.3 billion for Q2 2026, up 15710.87% on a QoQ basis from $46.0 million in Q1 2026, and up 3044.53% year-over-year from $231.3 million in Q2 2025.
Analysis
Danaher (DHR) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Danaher has reported Cash from Financing Activities for 18 years, with the latest figure at $7.3 billion in Q2 2026.
- On a quarterly basis, Cash from Financing Activities rose 3044.53% year-over-year to $7.3 billion in Q2 2026; TTM through Jun 2026 was $5.9 billion, a 245.09% increase from a year earlier, with the FY2025 full-year figure at -$3.0 billion, up 64.69% from the prior year.
- Cash from Financing Activities was $7.3 billion for Q2 2026 at Danaher, up from $46.0 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $7.3 billion in Q2 2026, with the low at -$5.7 billion in Q2 2024.
- Average Cash from Financing Activities over 5 years is -$381.7 million, with a median of -$268.0 million recorded in 2022.
- The sharpest annual moves came in 2024 and 2026: Cash from Financing Activities slumped 2647.6% in 2024, then surged 3044.53% in 2026.
- Over 5 years, Cash from Financing Activities stood at -$906.0 million in 2022, then slumped by 147.9% to -$2.2 billion in 2023, then gained by 24.67% to -$1.7 billion in 2024, then jumped by 178.13% to $1.3 billion in 2025, then soared by 450.15% to $7.3 billion in 2026.
- The last three Cash from Financing Activities figures came in at $7.3 billion (Q2 2026), $46.0 million (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 471.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -129.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -23.16 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -33.21 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -27.60 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -6.20 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 3.02 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 149.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 26, 2026 | 7.27 Bn |
| Mar 27, 2026 | 46.00 Mn |
| Dec 31, 2025 | 1.32 Bn |
| Sep 26, 2025 | -2.78 Bn |
| Jun 27, 2025 | -247.00 Mn |
| Mar 28, 2025 | -1.26 Bn |
| Dec 31, 2024 | -1.69 Bn |
| Sep 27, 2024 | -845.00 Mn |
| Jun 28, 2024 | -5.72 Bn |
| Mar 29, 2024 | -133.00 Mn |
| Dec 31, 2023 | -2.25 Bn |
| Sep 29, 2023 | 2.44 Bn |
| Jun 30, 2023 | -208.00 Mn |
| Mar 31, 2023 | -262.00 Mn |
| Dec 31, 2022 | -906.00 Mn |
| Sep 30, 2022 | -230.00 Mn |
| Jul 1, 2022 | -1.16 Bn |
| Apr 1, 2022 | -274.00 Mn |
| Dec 31, 2021 | -1.42 Bn |
| Oct 1, 2021 | 3.31 Bn |